In renal cancer, ADAM9 is significantly overexpressed compared to adjacent normal tissue, and its expression is associated with a higher tumour grade, positive nodal status, and distant metastasis and correlates with reduced patient survival in univariate analysis [69]. Here, ADAM9 is linked to neoplasm.